Bionomics Limited/Fi financial data

Symbol
BNOX on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Greenhill Road, Eastwood Sa, Australia
State of incorporation
Australia
Latest financial report
10-K - Q2 2024 - Sep 30, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.12B shares
Common Stock, Shares, Outstanding 2.38B shares +62.4%
Entity Public Float 13.3M USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.6M USD +4.17%
Accounts Receivable, after Allowance for Credit Loss, Current 127K USD -70.2%
Assets, Current 13.2M USD -1%
Property, Plant and Equipment, Net 1.99K USD -20.9%
Operating Lease, Right-of-Use Asset 217K USD -34.3%
Intangible Assets, Net (Excluding Goodwill) 5.47M USD -10.8%
Goodwill 8.69M USD -0.05%
Assets 27.6M USD -3.2%
Accounts Payable, Current 2.24M USD +55.9%
Liabilities, Current 3.83M USD +39.8%
Deferred Income Tax Liabilities, Net 964K USD -12.6%
Operating Lease, Liability, Noncurrent 118K USD -51%
Other Liabilities, Noncurrent 2.89K USD -80.6%
Liabilities 10.2M USD +55%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.01M USD +1.48%
Retained Earnings (Accumulated Deficit) -178M USD -9.54%
Stockholders' Equity Attributable to Parent 17.5M USD -20.5%
Liabilities and Equity 27.6M USD -3.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares, Issued 2.38B shares +62.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.7M USD +4.15%
Deferred Tax Assets, Gross 28.5M USD +18.3%
Operating Lease, Liability 240K USD -32.3%
Lessee, Operating Lease, Liability, to be Paid 376K USD
Property, Plant and Equipment, Gross 47.7K USD -0.09%
Operating Lease, Liability, Current 122K USD +7.08%
Lessee, Operating Lease, Liability, to be Paid, Year Two 183K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 193K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 137K USD
Additional Paid in Capital 198M USD +5.83%
Deferred Tax Assets, Net of Valuation Allowance 27.7M USD +18%